Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.92 USD | -3.03% | -9.43% | +10.35% |
Jun. 27 | BioRestorative Therapies, Inc. Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem® Metabolic Disease Program | CI |
Jun. 13 | Top Midday Gainers | MT |
Financials (USD)
Sales 2024 * | 580K | Sales 2025 * | 1.18M | Capitalization | 13M |
---|---|---|---|---|---|
Net income 2024 * | -16M | Net income 2025 * | -21M | EV / Sales 2024 * | 22.4 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 11 x |
P/E ratio 2024 * |
-0.93
x | P/E ratio 2025 * |
-0.88
x | Employees | 11 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 73.08% |
1 day | -3.03% | ||
1 week | -9.43% | ||
Current month | -5.42% | ||
1 month | +53.60% | ||
3 months | +44.36% | ||
6 months | +11.63% | ||
Current year | +10.35% |
Managers | Title | Age | Since |
---|---|---|---|
Lance Alstodt
CEO | Chief Executive Officer | 53 | 18-09-30 |
Robert Kristal
DFI | Director of Finance/CFO | - | 21-11-03 |
Compliance Officer | 55 | 15-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Patrick Williams
BRD | Director/Board Member | 51 | 21-10-28 |
David Rosa
BRD | Director/Board Member | 59 | 21-10-28 |
Francisco Silva
CTO | Chief Tech/Sci/R&D Officer | 49 | 11-04-12 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-02 | 1.92 | -3.03% | 58,239 |
24-07-01 | 1.98 | -2.46% | 89,988 |
24-06-28 | 2.03 | +10.93% | 121,283 |
24-06-27 | 1.83 | -9.41% | 383,978 |
24-06-26 | 2.02 | -4.72% | 105,202 |
Delayed Quote Nasdaq, July 02, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.35% | 13M | |
+16.44% | 122B | |
+18.94% | 113B | |
+18.60% | 26.22B | |
-25.37% | 19.01B | |
-20.00% | 15.71B | |
-20.20% | 15.22B | |
-47.37% | 14.72B | |
+59.91% | 14.58B | |
+4.35% | 13.84B |
- Stock Market
- Equities
- BRTX Stock